Table 6. Baseline and final plasma phospholipid EPA levels in patients in the experimental and control groups who completed 8-weeks oral supplementation.

	Control (n=12)	Experimental (n=7)	P
Baseline EPA (%)	0.91 (0.21)	0.94 (0.09)	0.933
Patients (n) with baseline EPA>1.6%	2	0	—
Final EPA (%)	1.70 (0.49)	5.57 (0.70)	0.001
Patients (n) with final EPA>1.6%	4	7	—

Values are mean (s.e.m.) with comparisons between groups by Student's t-test for independent samples.